Anti-Rad6/UBE2A (human) antibody rabbit polyclonal affinity-pure

Code:70-020

Resume of DNA synthesis which was halted by various physical and chemical factors
was triggered by repair system including Rad6. Rad6 (152a.a 17.3kDa) is the
ubiqutin-conjugated enzyme E2A and complex with two Rad18 molecules ubiquitin
ligase E3 to ubiquitinate PCNA by utilizing poly-ubiquitin chain that HLTF-UBC13
synthesized and they are involved in translesion DNA synthesis (TLS) and template switch (TS). Two isoforms of Rad6 Rad6A and Rad6B differs in only 6 amino acids. They also play an important role in epigenetic transcriptional regulation by catalyzing the monoubiquitination of histone H2B at Lys-120 .
Applications
1) Western blotting (1000~2000 fold dilution)
2) Immunoprecipitation (assay dependent)
3) Immunofluoscent staining (assay dependent)
Other applications have not been tested

anti-AlaRS (Alanine-tRNA Ligase) antibody rabbit serum

Code:70-600

AlaRS (968 amino acids 106.7 kDa) Alanine-tRNA ligase is an important enzyme that catalyzes addition of alanine to tRNA in protein synthesis utilizing ATP hydrolysis. AlaRS contains three domains; the N-terminal catalytic domain the editing domain and the C-terminal C-Ala domain. Also edits incorrectly charged tRNA(Ala) via its editing domain
Applications
1) Western blotting (100~1000 folds dilution)
Not tested for other applications

anti-Rad18 (mouse) antibody rabbit polyclonal IgG

Code:70-025

The Rad6 (UBE2B)-Rad18 pair of genes plays a critical role in post-replication repair
of damaged DNA. Rad6 protein functions as an E2 enzyme and Rad18 (509 aa 57.4
kDa) as a ubiquitine ligase (E3) which ubiquitinates PCNA. Rad18 recruits translesion
DNA polymerases to damaged DNA.
Applications (see Ref 1~3)
1) Western blotting (1000 fold dilution).
2) Immuno-precipitation (200~500 dilution))
3) Indirect immuno-fluorescence staining. (assay dependent)
4) Immuno-histochemistry (100~300 fold dilution)

anti-Rad51(human) antibody rabbit polyclonal affinity-pure

70-012

Shipped at 4℃ and stored at -20℃

Product: Polyclonal rabbit antiserum raised against full-size
functional recombinant Rad51 protein. Immunogen affinity-purified

Applications: Western blotting (X1000-3000 dilution).
Immunoprecipitation. ChIP. IF. ELISA. IHC

Reactivity: human mammalian chicken Xenopus

Form: 1 mg/ml in PBS with 50% Glycerol

anti-SUMO1 antibody rat monoclonal (4D12) Biotinylated

Code:70-654

SUMO (Small Ubiquitin-like Modifier) proteins are a family of small proteins that are covalently attached to and detached from other proteins in cells to modify their function. Unlike ubiquitination which targets proteins for degradation SUMO modification plays a critical role in a number of cellular functions including nucleocytoplasmic transport gene expression cell cycle and formation of subnuclear structures such as promyelocytic leukemia (PML) bodies. There are three confirmed SUMO isoforms in human; SUMO1 SUMO2 and SUMO3. SUMO2 /3 show a high degree of similarity to each other and are distinct from SUMO1. Individual SUMO family members are all targeted to different proteins with diverse biological functions. SUMO1 is conjugated to RanGAP PML p53 and IκB-α to regulate nuclear trafficking formation of subnuclear structures regulation of transcriptional activity and protein stability. SUMO1 is encoded as a 101 aa protein and first Met and C-terminal 4 aa are removed from the preprotein.
The antibody was produced from the hybridoma cultured in serum-free medium and purified under mild conditions by propriety chromatography processes.

Applications:
1. Western blotting 2. Immunofluorescence staining 3. Immunohistochemistry 4. ELISA Other applications have not been tested.

Anti-SUMO1 antibody rat monoclonal (4D12) FITC-conjugated

Code:70-655

SUMO (Small Ubiquitin-like Modifier) proteins are a family of small proteins that are covalently attached to and detached from other proteins in cells to modify their function. Unlike ubiquitination which targets proteins for degradation SUMO modification plays a critical role in a number of cellular functions including nucleocytoplasmic transport gene expression cell cycle and formation of subnuclear structures such as promyelocytic leukemia (PML) bodies. There are three confirmed SUMO isoforms in human; SUMO1 SUMO2 and SUMO3. SUMO2 /3 show a high degree of similarity to each other and are distinct from SUMO-1. Individual SUMO family members are all targeted to different proteins with diverse biological functions. SUMO-1 is conjugated to RanGAP PML p53 and IB- to regulate nuclear trafficking formation of subnuclear structures regulation of transcriptional activity and protein stability. SUMO1 is encoded as a 101 aa protein and first Met and C-terminal 4 aa are removed from the preprotein.

Anti-DNA polymerase eta (human) antibody mouse monoclonal (5H10)

Code:70-071

Key Words: DNA polymerase eta POLH Y-family DNA polymerase Xerderma pigmentosum variant type (XPV) Translesion DNA synthesis Error-prone DNA polymerase UV-sensitive DNA damage tolerance Skin cancer

Function: DNA polymerase eta ( 713 aa 78 kDa) is specifically involved in DNA repair. Plays an important
role in translesion synthesis where the normal high fidelity DNA polymerases cannot proceed and DNA
synthesis stalls. Plays an important role in the repair of UV-induced pyrimidine dimers. Depending on the
context it inserts the correct base but causes frequent base transitions and transversions. May play a role
in hypermutation at immunoglobulin genes. Forms a Schiff base with 5-deoxyribose phosphate at abasic
sites but does not have lyase activity. Targets POLI (Pol iota) to replication foci.
Involvement in disease: Xeroderma pigmentosum variant type (XPV) [MIM:278750]: An autosomal
recessive pigmentary skin disorder characterized by solar hypersensitivity of the skin high predisposition
for developing cancers on areas exposed to sunlight and in some cases neurological abnormalities. XPV
shows normal nucleotide excision repair but an exaggerated delay in recovery of replicative DNA
synthesis. Most patients with the variant type of xeroderma pigmentosum do not develop clinical
symptoms and skin neoplasias until a later age. Clinical manifestations are limited to photo-induced
deterioration of the skin and eyes.
Immunogen: Human recombinant full-size Pol eta tagged with His6.
Applications: Western blot. Not tested for other application

anti-TFIID subunit 1/TAF1/CCG1/KAT4 antibody rabbit serum

Code:70-457

Key words: TFIID subunit1 TAF1 CCG1 KAT4 TranscriptionTranscription initiation factor Transcription regulation Cell cycle Host-virus interaction protein kinase Bromo domain HMG box DNA-binding ATP-binding Nucleus Dystonia Parkinsonism

Function: TAFIID subunit1 (1872 aa 213 kDa) is the largest component and core scaffold of the TFIID basal transcription factor complex. Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors. Phosphorylates TP53 on Thr-55 which leads to MDM2-mediated degradation of TP53. Phosphorylates GTF2A1 and GTF2F1 on Ser residues. Possesses DNA-binding activity. Essential for progression of the G1 phase of the cell cycle.

Involvement in diseases: Dystonia 3 torsion X-linked (DYT3) [MIM:314250]: A X-linked dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions often leading to abnormal postures. DYT3 is characterized by severe progressive torsion dystonia followed by parkinsonism. It has a well-defined pathology of extensive neuronal loss and mosaic gliosis in the striatum (caudate nucleus and putamen) which appears to resemble that in Huntington disease.

Applications
1) Western blotting (1/1000 dilution)
2) Immunofluorescent staining (1/1000~1/5000)
Other applications have not been tested

Anti-Taf3 (S. cerevisiae) antibody rabbit polyclonal

Code:62-023

Taf3 functions as a component of the DNA-binding general transcription factor complex TFIID. Binding of TFIID to a promoter (with or without TATA element) is the initial step in pre-initiation complex (PIC) formation. TFIID plays a key role in the regulation of gene expression by RNA polymerase II through different activities such as transcription activator interaction core promoter recognition and selectivity TFIIA and TFIIB interaction chromatin modification (histone acetylation by TAF1) facilitation of DNA opening and initiation of transcription.

Taf3 consists of 353 amino acids with molecular mass of 40296 Da.

Anti-Taf7 (S. cerevisiae) antibody rabbit polyclonal

Code:62-024

Taf3 functions as a component of the DNA-binding general transcription factor complex TFIID. Binding of TFIID to a promoter (with or without TATA element) is the initial step in pre-initiation complex (PIC) formation. TFIID plays a key role in the regulation of gene expression by RNA polymerase II through different activities such as transcription activator interaction core promoter recognition and selectivity TFIIA and TFIIB interaction chromatin modification (histone acetylation by TAF1) facilitation of DNA opening and initiation of transcription. TAF7 is responsible for the recruitment of BDF1 to TATA element containing promoters.